Post X-Waiver Substance Use Disorder Training Module 9: Prescribing Medication for Opioid Use Disorder

Description

Register now for this online, self-guided course!

In this 1-hour interactive, virtual module, Dr. Wyatt, an addiction psychiatrist, will describe the medications for opioid use disorder and how to prescribe them. He will provide an understanding of how to use the three FDA approved medications most effectively for the treatment of opioid use disorders, with a focus on prescribing buprenorphine, especially in the age of fentanyl. Finally, he will explain how to assess clinical opioid withdrawal and how to manage withdrawal symptoms.

Approximate time to complete the course: 1 hour
Learner content includes: video and corresponding course handouts
Participants have unlimited time to complete this course and access course materials

This training module is part of a training suite that has been developed in accordance with the recommendations from the DEA and SAMHSA for the Medication Access and Training Expansion (MATE) Act. This requirement applies to physicians, physician assistants, nurse practitioners, podiatrists, dentists, and other practitioners that prescribe controlled substances who are applying for or renewing their DEA license after June 27, 2023.

Click here for more information and a full listing of modules available.


MAHEC engages in evaluation activities to better understand the impact of our programs. By registering for this course, you agree that we may use your personal information in evaluative research regarding this program. Any reports published will be de-identified and reported in aggregate format.

Scholarships

Limited scholarships are available on a first-come, first-served basis for Modules #9-#16 of this training suite. To request a scholarship for one or more modules please complete and submit your information on this scholarship request form. You will be notified via email within 48 hours of your submission whether or not you have been awarded a scholarship. Scholarships are provided by the Governor's Institute.

With Support from

Target Audience

This program is recommended for physicians, physician assistants, nurse practitioners, podiatrists, dentists, and other practitioners that prescribe controlled substances.

Objectives

• Apply your understanding of the pharmacology of the three FDA approved medications for the treatment of opioid use disorders in using them most effectively
• Apply a basic understanding of how to prescribe buprenorphine
• Demonstrate comfort assessing clinical opioid withdrawal and managing symptoms

Faculty

• Stephen A. Wyatt, DO, FAOAAM, FASAM